AR
Aaron Royston
OtherActiveManaging Partner at venBio Partners
39
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Aaron Royston.
Investment Thesis & Strategy
venBio Partners invests in various stages of biotech, healthcare, health IT, and pharmaceutical companies, seeking to partner with experienced management teams to build transformative businesses.
Investment Activity
Deals per year over the last 4 years
5
20185
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 39 companies
A
Ablaze Pharmaceuticals
Biotech · Seed, 2021
R
RayzeBio
Biotech · Seed, 2020
A
Artiva Biotherapeutics
Other · , 2019
E
Elevation Oncology
Biotech · Seed, 2019
I
INBRACE
Healthcare · Seed, 2019
T
Tallac Therapeutics
Other · , 2019
V
Ventyx Biosciences
Biotech · Seed, 2019
A
Arrakis Therapeutics
Biotech · Seed, 2018
F
Fog Pharmaceuticals
Biotech · Seed, 2018
P
Pharvaris
Biotech · Seed, 2018
A
Akero Therapeutics
Biotech · Seed, 2018
A
Attralus
Biotech · Seed, 2018
Frequently Asked Questions
Aaron Royston focuses on Series B stage investments.
Related Investors
Trevor Oelschig
San Francisco Bay Area, United States · 95 deals
Drew Harman
San Francisco Bay Area, United States · 94 deals
Ben Fletcher
San Francisco Bay Area, United States · 93 deals
Reva Nohria
San Francisco Bay Area, United States · 93 deals
Rajesh Swaminathan
San Francisco Bay Area, United States · 92 deals
Woody Marshall
San Francisco Bay Area, United States · 92 deals